Strategic Funding CMS recently secured a $1.2M investment from Impact Biotech, signaling validated market interest and potential for growth capital that sales teams can leverage to pursue larger contracts, strategic partnerships, or co-development opportunities.

Novel Delivery The company specializes in proprietary encapsulation and patented drug delivery platforms (Oral Thin Film, Oral Solutions, Topicals), presenting multiple entry points for formulation and manufacturing service sales across nutraceuticals, skincare, tinctures, and consumer health products.

Small Team, Flex With a lean team of 2-10 employees, CMS is likely to seek scalable, outsourced partnerships for clinical development, regulatory support, and bulk manufacturing capacity, offering outsized opportunities for strategic AOR (agency or partner) engagements.

Near-Term Growth Revenue is in the low-to-mid multi-million range and recent financing combined with ongoing innovation suggests momentum; a focused outreach on contract development and manufacturing services (CDMO) for complex formulations could yield repeat, high-margin engagements.

Market Expansion CMS aims to expand dosing loads and stabilize compounds to reach new markets; sales prospects exist with brands seeking advanced delivery systems, stability improvements, and broader formulation capabilities to scale edibles, drinks, creams, and other consumer medical products.